William R. Perry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
William R. Perry has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Kristine E. Konopka
Department of Pathology, University of Michigan, Ann Arbor, MI
2 shared publications - Anwar N. Mohamed
Pathology Department Detroit Medical Center Cytogenetics Laboratory Wayne State University School of Medicine Detroit MI USA
1 shared publication - David B. Chapel
Department of Pathology, University of Michigan, Ann Arbor, MI
1 shared publication Deborah Schloff
Pathology Department Detroit Medical Center Cytogenetics Laboratory Wayne State University School of Medicine Detroit MI USA
1 shared publication- Heather Chen-Yost
Department of Pathology Michigan Medicine, University of Michigan Ann Arbor Michigan USA
1 shared publication - Jeffrey Leon Myers
Department of Pathology, University of Michigan Medical School , Ann Arbor, MI
1 shared publication
Latest Publications
- Open Access
- 21 July 2025
- Published by Wiley in Histopathology
- Vol. 88 (2) , 533-537
Immunohistochemical characterization of peritoneal inclusion cysts with squamous metaplasia
Aims: Peritoneal inclusion cysts (PICs) are mesothelial‐lined cysts that can uncommonly develop squamous metaplasia. Here, we describe the immunophenotype of PICs with squamous metaplasia using a comprehensive immunohistochemical (IHC) panel. Methods and results: We collected surgical excisions of PICs with squamous metaplasia from our institution and cases sent to our extramural consultation service. An IHC panel was used to characterize the immunophenotype, which included antibodies to claudin 4, WT‐1, D2‐40, calretinin, CK5/6, p40/p63, PAX8, BAP1, MTAP and merlin. 10 cases of PICs with squamous metaplasia were identified. The average age was 51 years, with 8 females and 2 males. On histology, all PICs ( n = 10) showed diffuse squamous metaplasia. The cyst lining cells exhibited a squamous epithelial phenotype with diffuse expression of claudin 4 and p63/p40 in the suprabasal cells that also showed consistent co‐expression of WT1 in all cases. In contrast, the basal layer displayed a mesothelial phenotype, demonstrating immunoreactivity to WT1 and D2‐40 and lacking expression of claudin 4. Calretinin showed complete loss of expression in both the basal and parabasal cells. All cases showed retained expression of BAP1, MTAP and merlin. Conclusions: PICs with squamous metaplasia express a unique mixed epithelial and mesothelial immunophenotype. The basal layer shows an immunophenotype consistent with mesothelial cells, and the suprabasal layers show an immunophenotype consistent with epithelial/squamous cells. Knowing the detailed immunophenotype of PIC with squamous metaplasia is helpful for correctly recognizing this lesion.
- 21 July 2025
- Published by Wiley in Histopathology
- Vol. 88 (2) , 533-537
Open AccessImmunohistochemical characterization of peritoneal inclusion cysts with squamous metaplasia
Aims: Peritoneal inclusion cysts (PICs) are mesothelial‐lined cysts that can uncommonly develop squamous metaplasia. Here, we describe the immunophenotype of PICs with squamous metaplasia using a comprehensive immunohistochemical (IHC) panel. Methods and results: We collected surgical excisions of PICs with squamous metaplasia from our institution and cases sent to our extramural consultation service. An IHC panel was used to characterize the immunophenotype, which included antibodies to claudin 4, WT‐1, D2‐40, calretinin, CK5/6, p40/p63, PAX8, BAP1, MTAP and merlin. 10 cases of PICs with squamous metaplasia were identified. The average age was 51 years, with 8 females and 2 males. On histology, all PICs ( n = 10) showed diffuse squamous metaplasia. The cyst lining cells exhibited a squamous epithelial phenotype with diffuse expression of claudin 4 and p63/p40 in the suprabasal cells that also showed consistent co‐expression of WT1 in all cases. In contrast, the basal layer displayed a mesothelial phenotype, demonstrating immunoreactivity to WT1 and D2‐40 and lacking expression of claudin 4. Calretinin showed complete loss of expression in both the basal and parabasal cells. All cases showed retained expression of BAP1, MTAP and merlin. Conclusions: PICs with squamous metaplasia express a unique mixed epithelial and mesothelial immunophenotype. The basal layer shows an immunophenotype consistent with mesothelial cells, and the suprabasal layers show an immunophenotype consistent with epithelial/squamous cells. Knowing the detailed immunophenotype of PIC with squamous metaplasia is helpful for correctly recognizing this lesion.
- Open Access
- 8 February 2023
- Published by Wiley in Pathology International
- Vol. 73 (4) , 170-172
Primary mesenchymal chondrosarcoma of the lung
- 8 February 2023
- Published by Wiley in Pathology International
- Vol. 73 (4) , 170-172
Open AccessPrimary mesenchymal chondrosarcoma of the lung
- Open Access
- 1 October 2019
- Published by INIST-CNRS in Atlas of Genetics and Cytogenetics in Oncology and Haematology
- No. 8
Acute myeloid leukemia with t(12;13)(p13;q12) and ETV6 involvement; Case report and review of literature
Case report on acute myeloid leukemia with t(12;13)(p13;q12) and ETV6 involvement; Case report and review of literature. Clinics Age and sex 61 years old male patient.
- 1 October 2019
- Published by INIST-CNRS in Atlas of Genetics and Cytogenetics in Oncology and Haematology
- No. 8
Open AccessAcute myeloid leukemia with t(12;13)(p13;q12) and ETV6 involvement; Case report and review of literature
Case report on acute myeloid leukemia with t(12;13)(p13;q12) and ETV6 involvement; Case report and review of literature. Clinics Age and sex 61 years old male patient.